New York, Nov. 22 - AnorMed Inc. said it priced a C$25 million follow-on offering of common stock in a bought deal.
The company sold 6.25 million common shares at C$4.00 each, discounted from the closing level of C$4.13.
Raymond James Ltd. was lead manager with BMO Nesbitt Burns Inc., CIBC World Markets Inc. and Canaccord Capital Corp. also in the syndicate. The deal was offered in Canada via a short-form prospectus.
The sale has a greenshoe for 15% of the shares.
The Vancouver, B.C.-based biopharmaceutical company will use proceeds to fund the late stage and expanded clinical development of its drug development pipeline and for general corporate purposes.
| Issuer: | AnorMed Inc.
|
| Issue: | Follow-on stock offering
|
| Amount: | C$25 million
|
| Shares: | 6.25 million
|
| Greenshoe: | 15%
|
| Price: | C$4.00
|
| Lead manager: | Raymond James Ltd.
|
| Pricing date: | Nov. 22, after close
|
| Settlement: | Dec. 8
|
| Stock price: | C$4.13 at close Nov. 22
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
